Discontinuation report ALTACE HCT
| Report ID | 214024 |
| Drug Identification Number | 02283166 |
| Brand name | ALTACE HCT |
| Common or Proper name | ALTACE HCT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE RAMIPRIL |
| Strength(s) | 12.5MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | n/a |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2023-09-30 |
| Actual discontinuation date | 2024-01-08 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-01-09 | French | Compare |
| v3 | 2024-01-09 | English | Compare |
| v2 | 2023-12-21 | French | Compare |
| v1 | 2023-12-21 | English | Compare |
Showing 1 to 4 of 4